All News #Library
Biotech
Seyltx Gains Option to Boost Cough Pipeline with 8 NeurOp Drugs
05 Jun 2025 //
BUSINESSWIRE
Seyltx Reports Positive Pre-Clinical Data For GluN2B Inhibitor In Cough
16 Jul 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support